LB
5
-2
BMY
35
-2
LOW
39
3
MA
43
4
YUM
57
-5
WM
53
-14
PPL
62
2
MTCH
57
-11
CI
38
-10
BF.B
46
-4
HIG
51
-3
VRSK
33
-2
CVX
29
-2
GD
57
8
SJM
38
-5
BXP
54
2
EL
43
-2
SO
53
2
NWSA
71
-9
FE
41
4
LB
5
-2
BMY
35
-2
LOW
39
3
MA
43
4
YUM
57
-5
WM
53
-14
PPL
62
2
MTCH
57
-11
CI
38
-10
BF.B
46
-4
HIG
51
-3
VRSK
33
-2
CVX
29
-2
GD
57
8
SJM
38
-5
BXP
54
2
EL
43
-2
SO
53
2
NWSA
71
-9
FE
41
4
Financhill
Back

Brookfield Infrastructure Partners LP Vs. Lyra Therapeutics Industry Stock Comparison

Sell
44

BIP
Brookfield Infrastructure Partners LP

Last Price:
$32.20
Seasonality Move:
2.46%
Sell
15

LYRA
Lyra Therapeutics

Last Price:
$8.21
Seasonality Move:
-2.43%
Sell
44
Brookfield Infrastructure Partners LP (BIP) is a Sell

Is Brookfield Infrastructure Partners LP a Buy, Sell or Hold?

  • The current Brookfield Infrastructure Partners LP [BIP] share price is $32.29. The Score for BIP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BIP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Lyra Therapeutics (LYRA) is a Sell

Is Lyra Therapeutics a Buy, Sell or Hold?

  • The current Lyra Therapeutics [LYRA] share price is $8.15. The Score for LYRA is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • LYRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

BIP Stock Price Chart

What is Brookfield Infrastructure Partners LP's stock price today?

  • The Brookfield Infrastructure Partners LP share price today is $32.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIP is experiencing slight selling pressure.

LYRA Stock Price Chart

What is Lyra Therapeutics's stock price today?

  • The Lyra Therapeutics share price today is $8.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing slight selling pressure.

BIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 40.48 Sell
Chaikin Money Flow: -38260 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.45 - 33.49) Sell
Bollinger Bands (100): (29.16 - 33.2) Buy

LYRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.28 Buy
Relative Strength Index (14 RSI): 41.81 Sell
Chaikin Money Flow: -8233 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.31 - 11.29) Sell
Bollinger Bands (100): (3.93 - 12.99) Sell

BIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.44 Sell
20-day SMA: 33 Sell
50-day SMA: 32.94 Sell
200-day SMA: 32.39 Sell
8-day EMA: 32.52 Sell
20-day EMA: 32.79 Sell
50-day EMA: 32.53 Sell
200-day EMA: 31.86 Buy

LYRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.5 Sell
20-day SMA: 9.55 Sell
50-day SMA: 10.06 Sell
200-day SMA: 9.51 Sell
8-day EMA: 7.72 Buy
20-day EMA: 5.4 Buy
50-day EMA: 2.84 Buy
200-day EMA: 0.82 Buy

Brookfield Infrastructure Partners LP Earnings Growth & BIP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.21 per share, an increase this year of $0.72 per share, and an increase next year of $0.09 per share.

Lyra Therapeutics Earnings Growth & LYRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.

Brookfield Infrastructure Partners LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyra Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):